Blood Tests, Ultrasound, and Risk Assessment

The diagnostic workup for a multinodular goiter (MNG) is designed to answer two main questions: is your thyroid working too hard, and do any of the nodules look suspicious for cancer? Doctors use a combination of blood tests and high-resolution imaging to build a complete picture of your thyroid health ^[1][2].

Step 1: Checking Thyroid Function

The first step is almost always a blood test to measure TSH (Thyroid-Stimulating Hormone) ^[3]. TSH is produced by your brain to tell your thyroid how much hormone to make.

• Normal TSH: Your thyroid is generally not causing thyrotoxicosis, meaning it is “nontoxic.” Keep in mind that a “normal” result doesn’t guarantee everything is perfectly fine, but it shows your body isn’t in a state of hormone excess ^[4].
• Low TSH: This suggests your thyroid may be overactive (hyperthyroidism). If your TSH is low, your doctor will likely test your free T4 and free T3 levels to see exactly how much extra hormone is in your system. A low TSH with normal free T3/T4 is called subclinical hyperthyroidism ^[3][4].
• High TSH: This suggests an underactive thyroid (hypothyroidism), which may require different management ^[3].

Step 2: The Ultrasound and Risk Scoring

An ultrasound is the most important tool for looking at the physical structure of your nodules. Rather than just measuring size, doctors use standardized scoring systems—like the ACR TI-RADS or the ATA Guidelines—to determine the risk level of each nodule ^[5][6].

These systems assign points based on several “suspicious” features:

• Composition: Is the nodule solid, or is it a fluid-filled cyst? Solid nodules generally carry a higher risk than cystic or “spongiform” (sponge-like) ones ^[7].
• Echogenicity: This refers to how dark the nodule looks compared to the rest of the thyroid. Very dark (hypoechoic) nodules are more concerning ^[7][8].
• Margins: Smooth, clear edges are usually a good sign. Irregular, jagged, or “lobulated” edges may require a closer look ^[7].
• Calcifications: Small, bright spots called microcalcifications (or punctate echogenic foci) can sometimes be a sign of cancer ^[7][9].
• Shape: A nodule that is “taller than it is wide” is often considered more suspicious ^[8].

Step 3: When is a Specialized Scan Needed?

If your blood tests show a low TSH, your doctor may order a radioactive iodine uptake (RAI) scan or thyroid scintigraphy ^[10][11].

This scan helps identify “hot” and “cold” nodules:

• Hot Nodules: These nodules absorb a lot of iodine and produce extra hormone. These are almost always benign and rarely need a biopsy ^[11][12].
• Cold Nodules: These do not take up much iodine. A “cold” nodule is not a cancer diagnosis; most cold nodules are still benign. However, because they have a slightly higher risk of cancer compared to hot nodules, doctors evaluate them more closely using ultrasound ^[10][13].

Why Not Biopsy Everything?

In a multinodular goiter, it is common to have many nodules. It is standard medical practice not to biopsy every single one ^[14].

Instead, doctors use a selective approach based on specific guidelines:

• Risk-Based Size Thresholds: The size at which a nodule needs a biopsy depends on its ultrasound risk score. High-suspicion nodules might warrant a biopsy at 1 cm. Low-risk or very-low-risk nodules might not need a biopsy until they are 1.5 cm, 2.5 cm, or larger ^[15][16].
• Other Risk Factors: A smaller nodule might be biopsied if you have suspicious lymph nodes, a history of neck radiation, or a strong family history of thyroid cancer.
• Dominant vs. Suspicious: You may hear the term “dominant” nodule. This simply means it is the largest nodule in the goiter; it is not an independent cancer-risk category. Doctors prioritize biopsying “suspicious” nodules—those with high-risk features—even if they aren’t the dominant ones ^[9][17].

If your nodules do not meet the criteria for biopsy, your doctor will likely recommend active surveillance. This means re-checking them with an ultrasound. The follow-up interval is highly individualized—it could be 6 months, 12 months, or several years, depending on the nodule’s ultrasound pattern, cytology, and your personal risk factors ^[6][18].